Sektor Monte Rosa Therapeutics, Inc.

Aktien

A3CS44

US61225M1027

GLUE

Biotechnologie

Markt geschlossen - Nasdaq 22:00:00 13.07.2026 % 5 Tage Veränd. 1. Jan.
21.98 USD -4.60% Intraday Chart für Monte Rosa Therapeutics, Inc. -5.46% +40.18%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
-4.60%-5.46%+20.54%+25.24%+40.18%+325.97%+206.56%+18.24% - 1.86 Mrd.
-0.99%+1.39%+17.66%+10.09%+8.29%+3.15%+6.98%-12.00%+247.91% 50.61 Mrd.
-1.57%-3.18%+19.55%+34.96%+130.95%+383.82%+593.37%+480.10% - 39.11 Mrd.
-0.14%+0.77%+14.38%+20.68%-7.92%+27.49%-5.50%-16.86%+192.08% 34.64 Mrd.
+1.76%-1.78%+14.93%-0.55%+0.05%+21.44%+53.38%-7.99%+921.71% 33.79 Mrd.
-0.06%-0.45%+1.21%-5.81%+1.58%+2.94%+28.70%-19.02%+149.43% 26.89 Mrd.
-1.93%-1.01%+21.63% - - - - - - 16.47 Mrd.
-1.49%-6.18%+13.45%+5.78%-5.60%+63.89%+120.53%+188.92% - 15.14 Mrd.
-1.38%-0.58%+8.11%+0.06%+9.81%+13.90%+16.14%-32.93%+104.75% 13.85 Mrd.
-0.97%-2.83%+13.63%+50.49%-8.85%+10.35%-33.29%-20.91%+132.73% 12.72 Mrd.
-0.58%-5.84%+40.31%+12.96%-0.83%+1’537.86%+641.61%+305.43%+2’848.15% 11.8 Mrd.
-1.57%-0.73%+22.53%+28.83%+15.17%+44.13%+9.84%-40.03%+170.42% 11.07 Mrd.
+0.08%+0.62%+32.15%+24.04%+21.34%+31.81%-15.49%-37.05%+149.66% 11.12 Mrd.
-3.95%-7.86%+16.96%+21.64%-5.28%-1.67% - - - 10.04 Mrd.
+0.13%+0.24%+51.50%+54.28%+77.29%+250.87% - - - 10.03 Mrd.
-7.50%-3.80%+28.07%+24.70%+41.88%+148.20%+395.29%+126.51% - 9.08 Mrd.
-2.58%-31.77%-22.55%-24.28%-28.26%+35.99%+33.03%+56.08%+129.94% 9.38 Mrd.
-3.21%+0.34%+18.00%-0.77%+6.72%+522.40%+1’476.74%+11.19% - 8.77 Mrd.
-0.13%-5.93%+17.14%+53.69%+85.38%+71.30%+72.84%+112.23%+8.38% 8.65 Mrd.
-0.17%+5.85%+11.82%-1.12%-12.46%-18.20%-19.48%-21.24%+62.06% 8.57 Mrd.
Durchschnitt -1.29%-3.34%+18.05%+17.63%+19.44%+182.93%+210.66%+64.16%+426.44% 17.18 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung -0.83%-2.16%+16.87%+15.72%+22.15%+143.81%+171.88%+79.10%+413.99%
Biotechnologie und medizinische Forschung - Andere
  1. Börse
  2. Aktien
  3. A3CS44 Aktie
  4. Sektor Monte Rosa Therapeutics, Inc.